Balis FM - Search Results

1

A phase 1 study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 7 days every 21 days in pediatric patients with solid tumors.

Fox E, Maris JM, Widemann BC, Meek K, Goodwin A, Goodspeed W, Kromplewski M, Fouts ME, Medina D, Cho SY, Cohn SL, Krivoshik A, Hagey AE, Adamson PC, Balis FM. Fox E, et al. Among authors: balis fm. Clin Cancer Res. 2006 Aug 15;12(16):4882-7. doi: 10.1158/1078-0432.CCR-06-0534. Clin Cancer Res. 2006. PMID: 16914576 Clinical Trial.

2

Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.

Smith MA, Adamson PC, Balis FM, Feusner J, Aronson L, Murphy RF, Horowitz ME, Reaman G, Hammond GD, Fenton RM, et al. Smith MA, et al. Among authors: balis fm. J Clin Oncol. 1992 Nov;10(11):1666-73. doi: 10.1200/JCO.1992.10.11.1666. J Clin Oncol. 1992. PMID: 1403049 Clinical Trial.

3

Dose-dependent pharmacokinetics of all-trans-retinoic acid.

Adamson PC, Balis FM, Smith MA, Murphy RF, Godwin KA, Poplack DG. Adamson PC, et al. Among authors: balis fm. J Natl Cancer Inst. 1992 Sep 2;84(17):1332-5. doi: 10.1093/jnci/84.17.1332. J Natl Cancer Inst. 1992. PMID: 1495103

4

Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridine.

Blaney SM, Balis FM, Grem J, Cole DE, Adamson PC, Poplack DG. Blaney SM, et al. Among authors: balis fm. Cancer Res. 1992 Jun 15;52(12):3503-5. Cancer Res. 1992. PMID: 1596909

5

A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia.

Adamson PC, Zimm S, Ragab AH, Balis F, Steinberg SM, Kamen BA, Vietti TJ, Gillespie A, Poplack DG. Adamson PC, et al. Cancer Chemother Pharmacol. 1992;30(2):155-7. doi: 10.1007/BF00686410. Cancer Chemother Pharmacol. 1992. PMID: 1600597 Clinical Trial.

6

Methotrexate pharmacokinetics following administration of recombinant carboxypeptidase-G2 in rhesus monkeys.

Adamson PC, Balis FM, McCully CL, Godwin KS, Poplack DG. Adamson PC, et al. Among authors: balis fm. J Clin Oncol. 1992 Aug;10(8):1359-64. doi: 10.1200/JCO.1992.10.8.1359. J Clin Oncol. 1992. PMID: 1634927

7

Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.

Berg SL, Balis FM, Zimm S, Murphy RF, Holcenberg J, Sato J, Reaman G, Steinherz P, Gillespie A, Doherty K, et al. Berg SL, et al. Among authors: balis fm. J Clin Oncol. 1992 Jan;10(1):143-8. doi: 10.1200/JCO.1992.10.1.143. J Clin Oncol. 1992. PMID: 1727916 Clinical Trial.

8

Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule.

Adamson PC, Balis FM, Miser J, Arndt C, Wells RJ, Gillespie A, Aronson L, Penta JS, Clendeninn NJ, Poplack DG. Adamson PC, et al. Among authors: balis fm. Cancer Res. 1992 Feb 1;52(3):521-4. Cancer Res. 1992. PMID: 1732038 Clinical Trial.

9

Pharmacokinetics of pyrazoloacridine in the rhesus monkey.

Berg SL, Balis FM, McCully CL, Godwin KS, Poplack DG. Berg SL, et al. Among authors: balis fm. Cancer Res. 1991 Oct 15;51(20):5467-70. Cancer Res. 1991. PMID: 1913666

10

A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.

Grem JL, McAtee N, Murphy RF, Balis FM, Steinberg SM, Hamilton JM, Sorensen JM, Sartor O, Kramer BS, Goldstein LJ, et al. Grem JL, et al. Among authors: balis fm. J Clin Oncol. 1991 Oct;9(10):1811-20. doi: 10.1200/JCO.1991.9.10.1811. J Clin Oncol. 1991. PMID: 1919632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters